Skip to main content

Advertisement

SpringerLink
Log in

Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Increasing rates of extended-spectrum beta-lactamase (ESBL) producing E. coli and K. pneumoniae over time made empirical treatment complicated. Knowing local antimicrobial resistance patterns of common pathogens can make it easier to decide on empirical antibiotics. We aimed to investigate the prevalence and risk factors of ESBL positivity of E. coli and K. pneumoniae strains in uncomplicated and complicated pyelonephritis acquired in community and healthcare associations and to evaluate the appropriateness of empirical treatment. Adult patients hospitalized with diagnosis of community-acquired or healthcare-associated uncomplicated/complicated pyelonephritis initiated empirical antimicrobial therapy were included in the study. Appropriateness of empirical treatment at 48–72 h based on culture results and treatment modifications were evaluated. A total of 369 uncomplicated (94) and complicated (275) episodes of pyelonephritis were evaluated. The most common agents were E. coli (71.0%) and K. pneumoniae (17.7%), and the ESBL-production rate was 64.4%, and higher in healthcare-associated pyelonephritis (P 0.013). Being of healthcare-associated infection, previous antibiotic use, and presence of urinary catheters were independent risk factors for ESBL-producing E. coli and K. pneumoniae (P 0.009, < 0.001, and 0.024, respectively). The treatment inappropriateness was mostly associated with use of ceftriaxone (56.3%) (P < 0.001). Treatment has escalated in 41.5% of ceftriaxone-initiated patients, in only 8.8% and 9.5% ertapenem and piperacillin-tazobactam-initiated patients, respectively. ESBL-production rates are quite high even in community-acquired infections. The use of broad-spectrum antibiotics covering ESBL-producing pathogens to increase the appropriateness of empirical treatment and then narrowing treatment based on culture results appears a better and life-saving choice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Availability of data and materials

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Jamil I, Zafar A, Qamar MU, Ejaz H, Akhtar J, Waheed A (2014) Multi-drug resistant Klebsiella pneumoniae causing urinary tract infections in children in Pakistan. Afr J Microbiol Res 8(4):316–319. https://doi.org/10.5897/AJMR2013.6409

    Article  Google Scholar 

  2. Ramesh N, ve Sumathi CS, (2008) Urinary tract infection and antimicrobial susceptibility pattern of extended spectrum of beta lactamase producing clinical isolates. Biol Res 2:78–82

    Google Scholar 

  3. Khoshnood S, Heidary M, Mirnejad R, Bahramian A, Sedighi M, Mirzaei H (2017) Drug-resistant gram-negative uropathogens: a review. Biomed Pharmacother 94:982–994. https://doi.org/10.1016/j.biopha.2017.08.006

    Article  CAS  PubMed  Google Scholar 

  4. Nicolle LE, and AMMI Canada Guidelines Committee* (2005). Complicated urinary tract infection in adults. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 16(6):349–360. https://doi.org/10.1155/2005/385768

  5. Meier S, Weber R, Zbinden R, Ruef C, Hasse B (2011) Extended-spectrum β-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: An increasing challenge for antimicrobial therapy. Infection 39:333–340

    Article  CAS  Google Scholar 

  6. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A, Spanish Network for Research in Infectious Diseases (REIPI) (2010) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50(1):40–8. https://doi.org/10.1086/649537

    Article  CAS  PubMed  Google Scholar 

  7. Peña C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, Calatayud L, Ariza J, Gudiol F (2006) Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 12(3):279–284. https://doi.org/10.1111/j.1469-0691.2005.01358.x

    Article  PubMed  Google Scholar 

  8. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:103–120

    Article  Google Scholar 

  9. Sader HS, Castanheira M, Duncan LR, ve Flamm RK (2018) Antimicrobial susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa isolates from United States medical centers stratified by infection type: results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015–2016. Diagn Microbiol Infect Dis 92:69–74

    Article  CAS  Google Scholar 

  10. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Cruz FJ, Selvaggi FP (2003) EAU guidelines for the management of urinary and male genital tract infections1. Eur Urol 40:576–588

    Article  Google Scholar 

  11. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P et al (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis 50:625–663

    Article  Google Scholar 

  12. Sobel JD, Brown P (2020) Mandell, Douglas, and Bennett’s Principles and... Içinde Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, E. John, M. Bennett, M. Rapheal Dolin, ve M. Martin J. Blaser, ed., ss. 962–89

  13. Guglietta A (2017) Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 12:239–246

    Article  CAS  Google Scholar 

  14. Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc 315:801–810

    Article  CAS  Google Scholar 

  15. Ramakrishnan K, Scheid DC (2005) Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 71(5):933–942

    PubMed  Google Scholar 

  16. Cardoso T, Almeida M, Friedman ND, Aragão I, Costa-Pereira A, Sarmento AE, Azevedo L (2014) Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med 6(12):40. https://doi.org/10.1186/1741-7015-12-40

    Article  Google Scholar 

  17. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infec 18(3):268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x

    Article  CAS  Google Scholar 

  18. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; M100, CLSI, (2013–2016). Available from: https://clsi.org/media/2663/m100ed29_sample.pdf. Accessed 18 May 2021

  19. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269–284

    Article  CAS  Google Scholar 

  20. Doron S, Davidson LE (2011) Antimicrobial stewardship. Mayo Clin Proc 86, 1113–1123. Available at: https://doi.org/10.4065/mcp.2011.0358

  21. Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7:653–660. https://doi.org/10.1038/nrurol.2010.190

    Article  PubMed  Google Scholar 

  22. Finkelstein R, Kassis E, Reinhertz G, Gorenstein S, ve Herman, P. (1998) Community-acquired urinary tract infection in adults: a hospital viewpoint. J Hosp Infect 38:193–202

    Article  CAS  Google Scholar 

  23. Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56(5):914–8. https://doi.org/10.1093/jac/dki344

    Article  CAS  PubMed  Google Scholar 

  24. Antimicrobial resistance. Policy insights. https://www.oecd.org/health/health-systems/AMR-Policy-Insights-November2016.pdf. Access date 02 Feb 2021.

  25. Azap ÖK, Arslan H, Şerefhanoĝlu K, Çolakoĝlu Ş, Erdoĝan H, Timurkaynak F, Senger SS (2010) Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 16:147–151

    Article  CAS  Google Scholar 

  26. Zavala-Cerna MG, Segura-Cobos M, Gonzalez R, Zavala-Trujillo IG, Navarro-Perez SF, Rueda-Cruz JA, Satoscoy-Tovar FA (2020) The clinical significance of high antimicrobial resistance in community-acquired urinary tract infections. Can J Infect Dis Med Microbiol 2020:1–7

    Article  Google Scholar 

  27. Alshareef H, Alfahad W, Albaadani A, Alyazid H, Talib RB (2020). Impact of antibiotic de-escalation on hospitalized patients with urinary tract infections: a retrospective cohort single center study. J. Infect. Public Health 13, 985–990. Available at: https://doi.org/10.1016/j.jiph.2020.03.004

  28. Gupta K, Bhadelia N (2014) Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am 28, 49–59. Available at: https://doi.org/10.1016/j.idc.2013.10.002

  29. Umadevi S, Kandhakumari G, Joseph NM, Kumar S, Easow JM, Stephen S, Singh UK (2011) Prevalence and antimicrobial susceptibility pattern of ESBL producing gram negative bacilli. J Clin Diagnostic Res 5:236–239

    Google Scholar 

  30. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal GC, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother 57:780–783

    Article  CAS  Google Scholar 

  31. Karamanlıoğlu D, Aysert-Yıldız P, Kaya M, Sarı N (2019) Extended-spectrum β-lactamase production rates and antibiotic susceptibilities among Enterobacteriaceae isolated from urine cultures. Klimik Derg 32:233–239

    Article  Google Scholar 

  32. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JDD, Quentin C, Caibo ES, Azap ÖK, Arpin C, Pascual A, Livermore DM et al (2009) A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682–690

    Article  Google Scholar 

  33. Sierra-Díaz E, Hernández-Ríos CJ, Bravo-Cuellar A (2019). Antibiotic resistance: microbiological profile of urinary tract infections in Mexico. Cir y Cir (English Ed. 87, 176–182.

  34. Mert D, Çeken S, Ertek M (2020) The isolated bacteria from culture and antibiotic susceptibilities in urinary tract infections. Turk Hij ve Deney Biyol Derg 77:25–32

    Article  Google Scholar 

  35. Aksoy M, Isli F, Kadi E, Varimli D, Gursoz H, Tolunay T, Kara A, Unal S, Alp ME (2021) Evaluation of more than one billion outpatient prescriptions and eight-year trend showing a remarkable reduction in antibiotic prescription in Turkey: a success model of governmental interventions at national level. Pharmacoepidemiol Drug Saf 30(9):1242–1249. https://doi.org/10.1002/pds.5311s

    Article  PubMed  Google Scholar 

  36. Antimicrobial resistance. Policy insights. https://www.oecd.org/health/health-systems/AMR-Policy-Insights-November2016.pdf. 30 August 2021.

  37. Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Pedersen HB, Sautenkova N, Goossens H, WHO/Europe-ESAC Project Group (2014) Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 14(5):381–7. https://doi.org/10.1016/S1473-3099(14)70071-4

    Article  PubMed  Google Scholar 

  38. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797. https://doi.org/10.7326/0003-4819-137-10-200211190-00007

    Article  PubMed  Google Scholar 

  39. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128(6):3854–3862. https://doi.org/10.1378/chest.128.6.3854.  Erratum in: Chest. 2006 Mar;129(3):831

  40. Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60(5):913–920. https://doi.org/10.1093/jac/dkm318

    Article  CAS  PubMed  Google Scholar 

  41. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY; Korean Network for Study of Infectious Diseases (KONSID) (2010) Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 36(3):284–287. https://doi.org/10.1016/j.ijantimicag.2010.05.009

    Article  CAS  Google Scholar 

  42. Kim SH, Oh S, Huh K, Cho SY, Kang CI, Chung DR, Peck KR (2019) Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales. Eur J Clin Microbiol Infect Dis 38(5):937–944. https://doi.org/10.1007/s10096-019-03528-9

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey

    Bircan Kayaaslan, Imran Hasanoglu, Ayse Kaya Kalem, Fatma Eser & Rahmet Guner

  2. Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey

    Zeynep Oktay & Muge Ayhan

Authors
  1. Bircan Kayaaslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeynep Oktay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Imran Hasanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayse Kaya Kalem
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fatma Eser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Muge Ayhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rahmet Guner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bircan Kayaaslan.

Ethics declarations

Ethics approval

Ethics committee approval was received from Ankara City Hospital Ethics Committee 1 (Decision number: E1/1565/2021).

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kayaaslan, B., Oktay, Z., Hasanoglu, I. et al. Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results. Eur J Clin Microbiol Infect Dis 41, 421–430 (2022). https://doi.org/10.1007/s10096-021-04392-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-021-04392-2

Keywords

Search

Navigation